Carlos Arce-Lara, MD
Assistant Professor of Medicine
Carlos E. Arce-Lara, MD, is Assistant Professor of Medicine at the Medical College of Wisconsin Division of Hematology and Oncology, specializing in thoracic oncology and multiple myeloma at Froedtert Hospital. He graduated from Autonomous School of Medical Sciences (EACMCA) in San Jose, Costa Rica in 1999, he then completed his internal medicine residency at Mercy Catholic Medical Center in Philadelphia PA, and a Fellowship in Hematology and Oncology at The Ohio State University Medical Center. Dr. Arce-Lara served as an Assistant Professor of Medicine at Baylor College of Medicine in Houston Texas and before joining MCW he returned to his home country of Costa Rica for two years where he served as Assistant Professor in Medical Oncology at the Hospital San Juan de Dios. He has authored several publications, abstracts and poster presentations in national meetings. During training he was awarded the James Hifferty Jr. award for excellence in clinical medicine and was voted best fellow of the year in 2005. Dr. Arce-Lara is board certified in Internal Medicine, Medical Oncology, and Hematology.
Sonia M. Abuzakhm, Carlos Arce-Lara, et al.
Unusual Metastases of Gastrointestinal Stromal Tumor and
Genotypic Correlates: Case Report and Review of the Literature
J Gastrointest Oncol 2011; 2: 45-49.
Nse Nkutidem, Carlos Arce-Lara, et al
Capped-Dose Mitomycin C Pooled Safety Analysis from
Three Prospective Clinical Trials
Cancer Chemother Pharmacology. Volume 65 Number 2 319-324. 2010
DaGraca D, Yellapragada S, Yasin Z and Arce-Lara C
Retrospective analysis of multiple myeloma survival outcomes in veterans:
Focus on Racial differences, age and novel therapies.
ASCO American Society of Clinical Oncology Meeting #8127
Chicago, IL 2010
Arce-Lara C, Shah MH, Jimenez RE, Patel VP, Benson DM Jr., Clinton
SK, Monk JP
Gastrointestinal Stromal Tumors involving the prostate, presentation,
course and Therapeutic Approach.
Urology 2007 Jun;69(6):1209.e5-7.
Damian A. Laber, Roseline I. Okeke, Carlos Arce-Lara, Beverly S. Taft,
Cassandra L. Schonard, Kelly M. McMasters, Goetz H. Kloecker,
Donald M. Miller.
Phase II Study of Extended Dose Temozolomide and Thalidomide in the
Treatment of Poor Prognosis Metastatic Melanoma
J Cancer Res Clin Oncol 2006 Sep 132 (9): 611-616 Epub Jun 2 2006